Selda Pelin Kartal Durmazlar

*Department of Dermatology, Ministry of Health Ankara Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey* 

### **1. Introduction**

42 Venous Thrombosis – Principles and Practice

Zama, T.; Murata, M.; Ono, F.; Watanabe, K.; Watanabe, R.; Moriki, T.; Yokoyama, K.;

Zivelin, A.; Mor-Cohen, R.; Kovalsky, V.; Kornbrot, N.; Conard, J.; Peyvandi, F.; Kyrle, PA.;

Zöller, B.; Svensson, PJ.; He, X. & Dahlbäck, B. (1994). Identification of the same factor V

Zöller, B.; Hillarp, A. & Dahlbäck, B. (1997). Activated protein C resistance caused by a

*Hematology,* Vol.65, No.1, (December 1996), pp. 71-78, ISSN 0925-5710 Zivelin, A.; Griffin, JH.; Xu, X.; Pabinger, I.; Samama, M.; Conard, J.; Brenner, B.; Eldor, A. &

ISSN 0006-4971

1994), pp. 2521-2524, ISSN 0021-9738

(February 1997), pp. 237-243, ISSN 0049-3848

Tokuhira M, & Ikeda, Y. (1996). Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis, and normal individuals. *International Journal of* 

Seligsohn, U. (1997). A single genetic origin for a common Caucasian risk factor for venous thrombosis. *Blood,* Vol.89, No.2, (January 1997), pp. 397-402, ISSN 0006-4971

Bertina, R.; Peyvandi, F.; Emmerich, J. & Seligsohn, U. (2006). Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago. *Blood,* Vol.107, No.12, (June 2006), pp. 4666-4668,

gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. *Journal of Clinical Investigation,* Vol.94, No.6, (December

common factor V mutation has a single origin. *Thrombosis Research,* Vol.85, No.3,

Behcet's Disease (BD) is manifested by a triad of relapsing hypopyon uveitis, aphthous stomatitis and genital ulcers. The disease initially described by a Turkish dermatologist Hulusi Behcet in 1937. The etiology and pathogenesis of Behçet's disease have not been fully clarified yet. However, it is now recognized as a multisystemic, immunoinflammatory disorder involving vessels of all sizes. The disease is most prevalent in the Mediterranean countries, Middle East, and Japan but has a worldwide distribution (Durmazlar et al., 2009; Kartal Durmazlar et al., 2008a).
